Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

New Resource Page on Generalized Pustular Psoriasis

BI Resource Page on GPP graphic

Generalized Pustular Psoriasis (GPP) is a rare, lifelong skin disease that may be life-threatening if left untreated. It is characterized by flares that appear suddenly in the form of painful, pus-filled blisters over large body parts. It may be accompanied by more general symptoms, such as fever, headache, extreme tiredness, or a burning sensation on the skin. GPP can be confused with the more common plaque psoriasis, but they are distinct diseases.

Boehringer Ingelheim has created a resource page that includes the latest articles, downloads, and related press releases on GPP to assist with diagnosing and treating this rare disease.

Categories

Recent Posts

What Comes Next in Psoriasis Treatment: A Look at the Current Pipeline

When Cancer and Psoriasis Coexist: New IPC Guidance Puts Clarity Where It Is Needed Most

Reframing Obesity in Psoriatic Disease: From Pharmacokinetic Barrier to Therapeutic Target

Also Read

Biologic therapies

Focus on Psoriasis: Highlights from the 2025 EADV Congress

At the 2025 EADV Annual Meeting in Paris, experts shared new insights into psoriasis diagnosis, symptoms, and treatment. Highlights include the IPC Symposium, Free Communication sessions, and results from pivotal clinical trials on emerging oral peptides, IL-23 inhibitors, and dose-optimization strategies.

Read More

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

What's New

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Wednesday, September 9, 2026